Status:
UNKNOWN
Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
In 2017, 10.7 million people affiliated to the general health insurance scheme benefited from the "Long-term condition" scheme, i.e. 17% of insured patients. Most of these patients suffer from chronic...
Detailed Description
Context and hypothesis: In 2017, 10.7 million people affiliated to the French general health insurance scheme benefited from the "Long Term Affection" scheme that waives copayments related to long-ter...
Eligibility Criteria
Inclusion
- Patients aged 70 or older and/or identification of at least one of the chronic pathologies listed in the protocol before the start of confinement (03/17/2020, start of the 12th week of the year)
- Presence in the SNDS databases throughout the duration of the follow-up (12 months post-inclusion).
Exclusion
- None
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04907994
Start Date
September 1 2021
End Date
September 1 2023
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Paris - CHU Henri Mondor
Créteil, France, 94 010